Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

2.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

3.

Second opinions don't significantly delay breast cancer treatment

4.

Researchers study effects of cannabis on sedation, cancer treatment symptoms

5.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot